Companies: 10,795·Total market cap: $144.5T
Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc.

PLPLOTCFinancial Services● Active
$0.00
+$0.00(+900.00%)
Market Cap$4488953
P/E Ratio
52W High$0.0001
52W Low$0.00001

Plandaí Biotechnology, Inc. (PLPL) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PLPL · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$2,446 for FY2025 (fiscal year ending 2025-06-30), down 100.0% year-over-year. Net profit margin was —. Based on available data, Plandaí Biotechnology, Inc. has been profitable since at least 2022.

FY2025 Net Income−$2,446▼ -100.0% YoY
Trailing 12M (TTM)−$75,965trailing 4 quarters sum
Net Profit Margin
YoY Change-100.0%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2022

▸ FMP /income-statement · Annual · PLPL net income history · PLPL profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$2,446▼ 100.0%
FY2024$16.0M▲ +181.0%
FY2023Loss−$19.8M▼ 390.2%
FY2022★ First Profit$6.8M▲ +1818.9%
FY2021Loss−$397,000▼ 375.6%

Net income vs peers (Financial Services)

#CompanyNet IncomeYoY
#1
Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc.YOU
PLPL
−$2,446-100.0%
#2
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK-B
$66.97B-24.8%
#3
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
BRK-A
$66.97B-24.8%
#4
JPMorgan Chase & Co.
JPMorgan Chase & Co.
JPM
$57.05B-2.4%
#5
Visa Inc.
Visa Inc.
V
$20.06B+1.6%
#6
Mastercard Incorporated
Mastercard Incorporated
MA
$14.97B+16.3%
Financial Services · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Plandaí Biotechnology, Inc. (PLPL) reported net income of −$2,446 for FY2025 (fiscal year ending 2025-06-30), down 100.0% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Plandaí Biotechnology, Inc. has been profitable since at least 2022. Net income reached a peak of $16.0M in FY2024. Data available for 15 fiscal years.

Plandaí Biotechnology, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Plandaí Biotechnology, Inc. net worth" — the company's market capitalization is a separate figure from PLPL net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

PLPL net income · 4 questions

Plandaí Biotechnology, Inc. is not currently profitable on an annual basis. The company reported a net loss of $2,446 for FY2025.

is PLPL profitabledoes PLPL make a profitPLPL profitabilityPLPL profitable company

Source: FMP /income-statement · GAAP · Plandaí Biotechnology, Inc. · Plandaí Biotechnology, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026